I think this is a misreading of point #3. Ler
Post# of 148679
(Total Views: 469)
Posted On: 09/24/2024 5:03:28 PM
I think this is a misreading of point #3.
Leron results were statistically significant in terms of fibrosis reversal -- p<0.01
Resmetirom results in the same study were NOT statistically significant - p=0.057.
So Leron was clearly better than Resmetirom.
Incidentally, CYDyer is known to be short. He admits it.
Leron results were statistically significant in terms of fibrosis reversal -- p<0.01
Resmetirom results in the same study were NOT statistically significant - p=0.057.
So Leron was clearly better than Resmetirom.
Incidentally, CYDyer is known to be short. He admits it.
(13)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼